Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • News
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • News
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Rabbit Polyclonals
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Rabbit Polyclonals

[0399-CSB-PA618889LA01HU-20ug.] Rabbit Anti-Human GPR176 Polyclonal Antibody - trial size: 20ug.
Rabbit Anti-Human GPR176 Polyclonal Antibody - trial size: 20ug.
70.00 € 70.0 EUR
[0399-CSB-PA618889LA01HU-50ug.] Rabbit Anti-Human GPR176 Polyclonal Antibody - 50 ug.
Rabbit Anti-Human GPR176 Polyclonal Antibody - 50 ug.
275.00 € 275.0 EUR
[0399-CSB-PA618889LA01HU-100ug.] Rabbit Anti-Human GPR176 Polyclonal Antibody - 100 ug.
Rabbit Anti-Human GPR176 Polyclonal Antibody - 100 ug.
375.00 € 375.0 EUR
[0544-MBS8584152-0.1ML] Rabbit Anti-Human Aquaporin 3 (AQP3 ) Polyclonal Antibody - 0.1 mL
Rabbit Anti-Human Aquaporin 3 (AQP3 ) Polyclonal Antibody - 0.1 mL
482.00 € 482.0 EUR
[0197-STA-078] Rabbit Anti-Carbamyl-Lysine (CBL) Polyclonal Antibody, 50 ug.
Rabbit Anti-Carbamyl-Lysine (CBL) Polyclonal Antibody, 50 ug.
529.00 € 529.0 EUR
[0772-BT-AP07655-50UL] RANKL Polyclonal Antibody - 50 µL
RANKL Polyclonal Antibody - 50 µL
350.00 € 350.0 EUR
[0503-8103] Polyclonal antibody Vaccinia virus FITC 1 vial
Polyclonal antibody Vaccinia virus FITC 1 vial
575.00 € 575.0 EUR
[0503-8107] Polyclonal antibody Vaccinia virus Biotin 1 vial
Polyclonal antibody Vaccinia virus Biotin 1 vial
575.00 € 575.0 EUR
[0708-MOB-LX1103] Polyclonal Goat Anti-Rabbit, Mouse IgG Antibody (HRP) - 25 mL
Polyclonal Goat Anti-Rabbit, Mouse IgG Antibody (HRP) - 25 mL
1,958.00 € 1958.0 EUR
[0338- PAF959Hu01] Polyclonal Antibody to Utrophin (UTRN) 200ul
Polyclonal Antibody to Utrophin (UTRN) 200ul
607.00 € 607.0 EUR
[0338-PAA592Hu01-100UL] Polyclonal Antibody to Somatostatin (SST) - 100 ul
Polyclonal Antibody to Somatostatin (SST) - 100 ul
334.00 € 334.0 EUR
[0617-CAU21351-200] Polyclonal Antibody to Peroxidasin Homolog (PXDN)0 - 200ul
Polyclonal Antibody to Peroxidasin Homolog (PXDN)0 - 200ul
503.00 € 503.0 EUR
[0617-CAU21351-100] Polyclonal Antibody to Peroxidasin Homolog (PXDN)0 - 100ul
Polyclonal Antibody to Peroxidasin Homolog (PXDN)0 - 100ul
432.00 € 432.0 EUR
[0338-PAB052GE01-200UL] Polyclonal Antibody to Oxytocin (OT) - 200 ul (0.5mG./ml)
Polyclonal Antibody to Oxytocin (OT) - 200 ul (0.5mG./ml)
588.00 € 588.0 EUR
[0338-PAB052GE01-20UL] Polyclonal Antibody to Oxytocin (OT) - 20 ul (0.5mG./ml)
Polyclonal Antibody to Oxytocin (OT) - 20 ul (0.5mG./ml)
176.00 € 176.0 EUR
[0338-PAB459Ge01-200UL] Polyclonal Antibody to Ovalbumin (OVA) - 200 ul
Polyclonal Antibody to Ovalbumin (OVA) - 200 ul
299.00 € 299.0 EUR
[0338-PAB459Ge01-1ML] Polyclonal Antibody to Ovalbumin (OVA) - 1 mL
Polyclonal Antibody to Ovalbumin (OVA) - 1 mL
657.00 € 657.0 EUR
[0338-PAA686Mu01-200UL] Polyclonal Antibody to Mouse Cross Linked C-Telopeptide Of Type II Collagen (CTXII)
Polyclonal Antibody to Mouse Cross Linked C-Telopeptide Of Type II Collagen (CTXII)
502.50 € 502.5 EUR
[0338-PAB193Ga01-200UL] Polyclonal Antibody to Lysozyme (LZM) - 200 ul
Polyclonal Antibody to Lysozyme (LZM) - 200 ul
277.00 € 277.0 EUR
[0338-PAB193Ga01-1ML] Polyclonal Antibody to Lysozyme (LZM) - 1 mL
Polyclonal Antibody to Lysozyme (LZM) - 1 mL
603.00 € 603.0 EUR
  • 10
  • 11
  • 12
  • 13
  • 14

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)